Phil Rolland
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 4
- Cancer-related Molecular Pathways 3
- Cutaneous Melanoma Detection and Management 1
-
- Ubiquitin and proteasome pathways 1
- Epigenetics and DNA Methylation 1
- Co-authors
- Lindy G. Durrant (6 shared papers)Ian Spendlove (6 shared papers)Ian Scott (3 shared papers)Suha Deen (3 shared papers)Ian O. Ellis (2 shared papers)Timothy J. Duncan (3 shared papers)Zahra Madjd (1 shared paper)Robert Layfield (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (2 papers)International Journal of Cancer (2 papers)International Journal of Gynecological Pathology (1 paper)Journal of Lower Genital Tract Disease (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Phil Rolland
11 papers receiving 584 citations
Peers
Comparison fields: 5 of 52
- Obstetrics and Gynecology 126
- Reproductive Medicine 101
- Immunology 146
- Oncology 176
- Cancer Research 75
Countries citing papers authored by Phil Rolland
This map shows the geographic impact of Phil Rolland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Rolland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Rolland more than expected).
Fields of papers citing papers by Phil Rolland
This network shows the impact of papers produced by Phil Rolland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Rolland. The network helps show where Phil Rolland may publish in the future.
Co-authors
The 25 scholars most cited alongside Phil Rolland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 110 | |
| 2 | 2008 | 99 | |
| 3 | 2007 | 98 | |
| 4 | 2010 | 76 | |
| 5 | 2007 | 50 | |
| 6 | 2006 | 44 | |
| 7 | 2007 | 41 | |
| 8 | 2020 | 39 | |
| 9 | 2009 | 24 | |
| 10 | 2019 | 15 | |
| 11 | 2020 | 7 |
About Phil Rolland
Phil Rolland is a scholar working on Oncology, Molecular Biology, Obstetrics and Gynecology, Reproductive Medicine and Immunology, having authored 11 papers that have together received 603 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer-related Molecular Pathways (3 papers), Endometriosis Research and Treatment (1 paper), Ubiquitin and proteasome pathways (1 paper), Epigenetics and DNA Methylation (1 paper), Immunotherapy and Immune Responses (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Obstetrics and Gynecology (126 citations), Reproductive Medicine (101 citations), Immunology (146 citations), Oncology (176 citations) and Cancer Research (75 citations). Phil Rolland has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lindy G. Durrant, Ian Spendlove, Ian Scott, Suha Deen, Ian O. Ellis, Timothy J. Duncan, Zahra Madjd, Robert Layfield, Ahmad Al‐Attar and John Trowsdale. Their work appears in journals such as Clinical Cancer Research, European Journal of Obstetrics & Gynecology and Reproductive Biology, International Journal of Cancer, International Journal of Gynecological Pathology and Journal of Lower Genital Tract Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.